Go to deals
Private Equity | Healthcare | TMT

Global Media Santé has been acquired by SFP Expansion

October 2020 — Global Media Santé’s CEO, Alain Trébucq, and Apax Partners have sold the company to SFP Expansion Group.

Global Media Santé is an information and training company dedicated to health professionals. It publishes print and digital medical content addressed to doctors as well as medical students and other health professionals. Its prestigious trademarks include La Revue du Praticien, Le Concours Médical and Egora Le Panorama du Médecin. It also provides e-learning modules falling within French doctors’ mandatory continuing professional development. The strength of its business model relies on the diversity of its revenue sources: reader subscriptions, advertising and e-learning.

SFP Expansion Group, via its company Santé Formapro, is a provider of continuing professional development content for health professionals. Its 10,000-yearly e-learning lessons address doctors, nurses and physiotherapists.

Apax Partners is a leading European private equity firm. With more than 45 years of experience, it provides long-term equity funding to build and strengthen world-class companies. Funds managed and advised by Apax Partners exceed US$4 billion. These funds invest in fast-growing middle-market companies across four sectors: TMT, consumer, healthcare and services.

Our role in the transaction

Oaklins’ team in France acted as sell-side financial advisor to Global Media Santé’s CEO and Apax Partners in this transaction.

Parties
“Oaklins’ support has been very valuable throughout the process which began the day I met SFP Expansion’s chairman Jean-Eric Lucas. The team were able to perfectly comprehend Global Media Santé’s requirements and its synergies with SFP Expansion. I am personally very happy to be at the side of SFP Expansion for the integration of Global Media Santé, while deepening the digital transformation engaged three years ago.”

Alain Trébucq

CEO, Global Media Santé

Talk to the deal team

Thibaut de Monclin

Managing Partner
Paris, France
Oaklins France

Related deals

Comtax has been acquired by Ryan
Private Equity | Business Support Services | TMT

Comtax has been acquired by Ryan

Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.

Learn more
Cibus has acquired Aweta from Standard Investment
Private Equity | Agriculture | Industrial Machinery & Components

Cibus has acquired Aweta from Standard Investment

Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.

Learn more
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Healthcare

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Learn more